{"id":17365,"date":"2024-02-06T15:34:01","date_gmt":"2024-02-06T20:34:01","guid":{"rendered":"https:\/\/www.ices.on.ca\/?post_type=private_project&#038;p=17365"},"modified":"2025-02-28T08:50:53","modified_gmt":"2025-02-28T13:50:53","slug":"burden-of-illness-and-healthcare-resource-utilization-of-patients-with-metabolic-dysfunction","status":"publish","type":"private_project","link":"https:\/\/www.ices.on.ca\/fr\/services-for-researchers\/all-projects\/private-sector-projects\/burden-of-illness-and-healthcare-resource-utilization-of-patients-with-metabolic-dysfunction\/","title":{"rendered":"Burden of illness and healthcare resource utilization of patients with metabolic dysfunction associated steatotic liver disease (MASLD) and metabolic dysfunction associated steato-hepatitis (MASH) in Ontario"},"content":{"rendered":"<p><strong>Client:<\/strong> IQVIA Solutions Canada Inc.<\/p>\n<p><strong>Project ID:<\/strong> P2023-190\/ 2024 0970 375 000<\/p>\n<p><strong>Research Question\/Objectives:<\/strong> The client has several objectives around patient demographics, healthcare resource utilization, and health outcomes for Metabolic Dysfunction Associated Steatotic Liver Disease (MASLD).<\/p>\n<p><strong>Objectives:<\/strong><\/p>\n<ul>\n<li>To describe key patient demographic (e.g., age, sex) and clinical characteristics (e.g., year of index date, presence of comorbidities, Charlson Comorbidity Index (CCI)) of the study cohort and subgroups, in Ontario, Canada<\/li>\n<li>To describe the all-cause healthcare resource utilization (HCRU) and direct costs to the public payer of the study cohort and subgroups following index date and compare to their respective matched general population controls in Ontario, Canada<\/li>\n<li>To describe health outcomes (e.g., cardiac events, liver cirrhosis, liver transplant, liver cancer) of the study cohort and subgroups following index date and compare to matched general population controls in Ontario, Canada<\/li>\n<\/ul>\n<p><strong>Results:<\/strong> Completed<\/p>\n<p><strong>Results:<\/strong> September 2025<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Client: IQVIA Solutions Canada Inc. Project ID: P2023-190\/ 2024 0970 375 000 Research Question\/Objectives: The client has several objectives around patient demographics, healthcare resource utilization, and health outcomes for Metabolic Dysfunction Associated Steatotic Liver Disease (MASLD). Objectives: To describe key patient demographic (e.g., age, sex) and clinical characteristics (e.g., year of index date, presence of [&hellip;]<\/p>\n","protected":false},"template":"","organization_type":[],"project_status":[105],"response_type":[],"class_list":["post-17365","private_project","type-private_project","status-publish","hentry","project_status-completed"],"acf":{"project_id":"P2023-190\/ 2024 0970 375 000","project_id_year":2024,"ices_scientist":"","principal_investigators":null,"knowledge_user":"","client":"","objectives":"","results":"","availability_of_results":"","pia_approved":null,"infographic":"","sitecore_item_id":"","sitecore_item_name":"","sitecore_field_values":""},"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v28.0 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Burden of illness and healthcare resource utilization of patients with metabolic dysfunction associated steatotic liver disease (MASLD) and metabolic dysfunction associated steato-hepatitis (MASH) in Ontario | ICES<\/title>\n<meta name=\"description\" content=\"Client: IQVIA Solutions Canada Inc. Project ID: P2023-190\/ 2024 0970 375 000 Research Question\/Objectives: The client has several objectives around\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.ices.on.ca\/fr\/services-for-researchers\/all-projects\/private-sector-projects\/burden-of-illness-and-healthcare-resource-utilization-of-patients-with-metabolic-dysfunction\/\" \/>\n<meta property=\"og:locale\" content=\"fr_FR\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Burden of illness and healthcare resource utilization of patients with metabolic dysfunction associated steatotic liver disease (MASLD) and metabolic dysfunction associated steato-hepatitis (MASH) in Ontario | ICES\" \/>\n<meta property=\"og:description\" content=\"Client: IQVIA Solutions Canada Inc. Project ID: P2023-190\/ 2024 0970 375 000 Research Question\/Objectives: The client has several objectives around\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.ices.on.ca\/fr\/services-for-researchers\/all-projects\/private-sector-projects\/burden-of-illness-and-healthcare-resource-utilization-of-patients-with-metabolic-dysfunction\/\" \/>\n<meta property=\"og:site_name\" content=\"ICES\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/ICESOntario\/\" \/>\n<meta property=\"article:modified_time\" content=\"2025-02-28T13:50:53+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.ices.on.ca\/wp-content\/uploads\/2024\/11\/ic-es-data-discovery-better-health-logo.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"1200\" \/>\n\t<meta property=\"og:image:height\" content=\"675\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.ices.on.ca\\\/fr\\\/services-for-researchers\\\/all-projects\\\/private-sector-projects\\\/burden-of-illness-and-healthcare-resource-utilization-of-patients-with-metabolic-dysfunction\\\/\",\"url\":\"https:\\\/\\\/www.ices.on.ca\\\/fr\\\/services-for-researchers\\\/all-projects\\\/private-sector-projects\\\/burden-of-illness-and-healthcare-resource-utilization-of-patients-with-metabolic-dysfunction\\\/\",\"name\":\"Burden of illness and healthcare resource utilization of patients with metabolic dysfunction associated steatotic liver disease (MASLD) and metabolic dysfunction associated steato-hepatitis (MASH) in Ontario | ICES\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.ices.on.ca\\\/fr\\\/#website\"},\"datePublished\":\"2024-02-06T20:34:01+00:00\",\"dateModified\":\"2025-02-28T13:50:53+00:00\",\"description\":\"Client: IQVIA Solutions Canada Inc. Project ID: P2023-190\\\/ 2024 0970 375 000 Research Question\\\/Objectives: The client has several objectives around\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.ices.on.ca\\\/fr\\\/services-for-researchers\\\/all-projects\\\/private-sector-projects\\\/burden-of-illness-and-healthcare-resource-utilization-of-patients-with-metabolic-dysfunction\\\/#breadcrumb\"},\"inLanguage\":\"fr-FR\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.ices.on.ca\\\/fr\\\/services-for-researchers\\\/all-projects\\\/private-sector-projects\\\/burden-of-illness-and-healthcare-resource-utilization-of-patients-with-metabolic-dysfunction\\\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.ices.on.ca\\\/fr\\\/services-for-researchers\\\/all-projects\\\/private-sector-projects\\\/burden-of-illness-and-healthcare-resource-utilization-of-patients-with-metabolic-dysfunction\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.ices.on.ca\\\/fr\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Private Sector Projects\",\"item\":\"https:\\\/\\\/www.ices.on.ca\\\/fr\\\/services-for-researchers\\\/all-projects\\\/private-sector-projects\\\/\"},{\"@type\":\"ListItem\",\"position\":3,\"name\":\"Burden of illness and healthcare resource utilization of patients with metabolic dysfunction associated steatotic liver disease (MASLD) and metabolic dysfunction associated steato-hepatitis (MASH) in Ontario\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.ices.on.ca\\\/fr\\\/#website\",\"url\":\"https:\\\/\\\/www.ices.on.ca\\\/fr\\\/\",\"name\":\"ICES\",\"description\":\"POPULATION-BASED HEALTH RESEARCH THAT MAKES A DIFFERENCE\",\"publisher\":{\"@id\":\"https:\\\/\\\/www.ices.on.ca\\\/fr\\\/#organization\"},\"alternateName\":\"Institute for Clinical Evaluative Sciences\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.ices.on.ca\\\/fr\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"fr-FR\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/www.ices.on.ca\\\/fr\\\/#organization\",\"name\":\"ICES\",\"alternateName\":\"Institute for Clinical Evaluative Sciences\",\"url\":\"https:\\\/\\\/www.ices.on.ca\\\/fr\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\\\/\\\/www.ices.on.ca\\\/fr\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/www.ices.on.ca\\\/wp-content\\\/uploads\\\/2023\\\/04\\\/ices-logo.png\",\"contentUrl\":\"https:\\\/\\\/www.ices.on.ca\\\/wp-content\\\/uploads\\\/2023\\\/04\\\/ices-logo.png\",\"width\":\"676\",\"height\":\"618\",\"caption\":\"ICES\"},\"image\":{\"@id\":\"https:\\\/\\\/www.ices.on.ca\\\/fr\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/www.facebook.com\\\/ICESOntario\\\/\",\"https:\\\/\\\/www.linkedin.com\\\/company\\\/ices-research-institute\\\/\"]}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Burden of illness and healthcare resource utilization of patients with metabolic dysfunction associated steatotic liver disease (MASLD) and metabolic dysfunction associated steato-hepatitis (MASH) in Ontario | ICES","description":"Client: IQVIA Solutions Canada Inc. Project ID: P2023-190\/ 2024 0970 375 000 Research Question\/Objectives: The client has several objectives around","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.ices.on.ca\/fr\/services-for-researchers\/all-projects\/private-sector-projects\/burden-of-illness-and-healthcare-resource-utilization-of-patients-with-metabolic-dysfunction\/","og_locale":"fr_FR","og_type":"article","og_title":"Burden of illness and healthcare resource utilization of patients with metabolic dysfunction associated steatotic liver disease (MASLD) and metabolic dysfunction associated steato-hepatitis (MASH) in Ontario | ICES","og_description":"Client: IQVIA Solutions Canada Inc. Project ID: P2023-190\/ 2024 0970 375 000 Research Question\/Objectives: The client has several objectives around","og_url":"https:\/\/www.ices.on.ca\/fr\/services-for-researchers\/all-projects\/private-sector-projects\/burden-of-illness-and-healthcare-resource-utilization-of-patients-with-metabolic-dysfunction\/","og_site_name":"ICES","article_publisher":"https:\/\/www.facebook.com\/ICESOntario\/","article_modified_time":"2025-02-28T13:50:53+00:00","og_image":[{"width":1200,"height":675,"url":"https:\/\/www.ices.on.ca\/wp-content\/uploads\/2024\/11\/ic-es-data-discovery-better-health-logo.jpg","type":"image\/jpeg"}],"twitter_card":"summary_large_image","schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/www.ices.on.ca\/fr\/services-for-researchers\/all-projects\/private-sector-projects\/burden-of-illness-and-healthcare-resource-utilization-of-patients-with-metabolic-dysfunction\/","url":"https:\/\/www.ices.on.ca\/fr\/services-for-researchers\/all-projects\/private-sector-projects\/burden-of-illness-and-healthcare-resource-utilization-of-patients-with-metabolic-dysfunction\/","name":"Burden of illness and healthcare resource utilization of patients with metabolic dysfunction associated steatotic liver disease (MASLD) and metabolic dysfunction associated steato-hepatitis (MASH) in Ontario | ICES","isPartOf":{"@id":"https:\/\/www.ices.on.ca\/fr\/#website"},"datePublished":"2024-02-06T20:34:01+00:00","dateModified":"2025-02-28T13:50:53+00:00","description":"Client: IQVIA Solutions Canada Inc. Project ID: P2023-190\/ 2024 0970 375 000 Research Question\/Objectives: The client has several objectives around","breadcrumb":{"@id":"https:\/\/www.ices.on.ca\/fr\/services-for-researchers\/all-projects\/private-sector-projects\/burden-of-illness-and-healthcare-resource-utilization-of-patients-with-metabolic-dysfunction\/#breadcrumb"},"inLanguage":"fr-FR","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.ices.on.ca\/fr\/services-for-researchers\/all-projects\/private-sector-projects\/burden-of-illness-and-healthcare-resource-utilization-of-patients-with-metabolic-dysfunction\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/www.ices.on.ca\/fr\/services-for-researchers\/all-projects\/private-sector-projects\/burden-of-illness-and-healthcare-resource-utilization-of-patients-with-metabolic-dysfunction\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.ices.on.ca\/fr\/"},{"@type":"ListItem","position":2,"name":"Private Sector Projects","item":"https:\/\/www.ices.on.ca\/fr\/services-for-researchers\/all-projects\/private-sector-projects\/"},{"@type":"ListItem","position":3,"name":"Burden of illness and healthcare resource utilization of patients with metabolic dysfunction associated steatotic liver disease (MASLD) and metabolic dysfunction associated steato-hepatitis (MASH) in Ontario"}]},{"@type":"WebSite","@id":"https:\/\/www.ices.on.ca\/fr\/#website","url":"https:\/\/www.ices.on.ca\/fr\/","name":"ICES","description":"POPULATION-BASED HEALTH RESEARCH THAT MAKES A DIFFERENCE","publisher":{"@id":"https:\/\/www.ices.on.ca\/fr\/#organization"},"alternateName":"Institute for Clinical Evaluative Sciences","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.ices.on.ca\/fr\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"fr-FR"},{"@type":"Organization","@id":"https:\/\/www.ices.on.ca\/fr\/#organization","name":"ICES","alternateName":"Institute for Clinical Evaluative Sciences","url":"https:\/\/www.ices.on.ca\/fr\/","logo":{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/www.ices.on.ca\/fr\/#\/schema\/logo\/image\/","url":"https:\/\/www.ices.on.ca\/wp-content\/uploads\/2023\/04\/ices-logo.png","contentUrl":"https:\/\/www.ices.on.ca\/wp-content\/uploads\/2023\/04\/ices-logo.png","width":"676","height":"618","caption":"ICES"},"image":{"@id":"https:\/\/www.ices.on.ca\/fr\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/ICESOntario\/","https:\/\/www.linkedin.com\/company\/ices-research-institute\/"]}]}},"_links":{"self":[{"href":"https:\/\/www.ices.on.ca\/fr\/wp-json\/wp\/v2\/private_project\/17365","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.ices.on.ca\/fr\/wp-json\/wp\/v2\/private_project"}],"about":[{"href":"https:\/\/www.ices.on.ca\/fr\/wp-json\/wp\/v2\/types\/private_project"}],"wp:attachment":[{"href":"https:\/\/www.ices.on.ca\/fr\/wp-json\/wp\/v2\/media?parent=17365"}],"wp:term":[{"taxonomy":"organization_type","embeddable":true,"href":"https:\/\/www.ices.on.ca\/fr\/wp-json\/wp\/v2\/organization_type?post=17365"},{"taxonomy":"project_status","embeddable":true,"href":"https:\/\/www.ices.on.ca\/fr\/wp-json\/wp\/v2\/project_status?post=17365"},{"taxonomy":"response_type","embeddable":true,"href":"https:\/\/www.ices.on.ca\/fr\/wp-json\/wp\/v2\/response_type?post=17365"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}